The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Altimmune Inc (NASDAQ: ALT) was $5.61 for the day, down -6.03% from the previous closing price of $5.97. In other words, the price has decreased by -$6.03 from its previous closing price. On the day, 2.52 million shares were traded. ALT stock price reached its highest trading level at $5.89 during the session, while it also had its lowest trading level at $5.48.
Ratios:
Our analysis of ALT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 13.10 and its Current Ratio is at 13.10. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On January 08, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $18.
On November 12, 2024, UBS started tracking the stock assigning a Buy rating and target price of $26.UBS initiated its Buy rating on November 12, 2024, with a $26 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 17 ’25 when Sohn Catherine A. bought 1,000 shares for $5.78 per share. The transaction valued at 5,784 led to the insider holds 1,000 shares of the business.
WEAVER GREGORY L bought 10,000 shares of ALT for $51,996 on Mar 13 ’25. The Chief Financial Officer now owns 10,000 shares after completing the transaction at $5.20 per share. On Aug 19 ’24, another insider, Drutz David, who serves as the Director of the company, sold 16,011 shares for $6.90 each. As a result, the insider received 110,547 and left with 41,958 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALT now has a Market Capitalization of 459771456 and an Enterprise Value of 301836608. For the stock, the TTM Price-to-Sale (P/S) ratio is 21602.50 while its Price-to-Book (P/B) ratio in mrq is 3.29. Its current Enterprise Value per Revenue stands at 15091.831 whereas that against EBITDA is -2.932.
Stock Price History:
The Beta on a monthly basis for ALT is 0.81, which has changed by -0.39935762 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, ALT has reached a high of $11.16, while it has fallen to a 52-week low of $5.14. The 50-Day Moving Average of the stock is -12.92%, while the 200-Day Moving Average is calculated to be -19.37%.
Shares Statistics:
ALT traded an average of 2.66M shares per day over the past three months and 4101200 shares per day over the past ten days. A total of 77.01M shares are outstanding, with a floating share count of 76.21M. Insiders hold about 1.04% of the company’s shares, while institutions hold 53.06% stake in the company. Shares short for ALT as of 1740700800 were 21665305 with a Short Ratio of 8.14, compared to 1738281600 on 23319504. Therefore, it implies a Short% of Shares Outstanding of 21665305 and a Short% of Float of 28.360000000000003.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
